Patent · US Expired

Adenocarcinoma specific antibody SAM-6, and uses thereof

US8163552B2 · kind B2 · utility

0Cited by

11References

23Claims

0Family size

Assignee

Patrys Limited · AU

Inventors

Heinz Peter Vollmers · Coburg, DE
Hans-Konrad Muller-Hermelink · Würzburg, DE

Key dates

Filing date	Nov 12, 2004
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Nov 12, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A purified polypeptide that binds to neoplastic cells, which may be an antibody, is produced by the hybridoma SAM-6, a method for its production and use in the treatment and diagnosis of neoplasms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.